Commercial Strategy Consulting

US-based economic consulting firm with published outcomes and cost-effectiveness analyses on esketamine treatment pathways relevant to payer decision-making and market access strategy.

Consultant Agency for Psychedelic Services (CAPS) is a UK-based advisory practice led by Dr Ben Sessa, providing consultancy for individuals, clinics, companies, and investors developing psychedelic and medical-cannabis services.

Economic and strategy consultancy with life sciences advisory services, including published analysis on the evolving psychedelic therapeutics landscape and market implications.

Psychedelic-focused consultancy providing strategic advisory, market mapping, and reimbursement insights to investors, healthcare organizations, and policy stakeholders.

Global strategy consultancy with US/EU healthcare practices and published analysis on psychedelic treatment pathways, funding dynamics, and commercialization implications.

Global commercialization and market access advisory firm with published commentary on positioning psychedelic medicines within biopharmaceutical development frameworks.

UK-based psychedelic-focused consultancy offering strategic and business development services, education curriculum design, and partner collaborations for organizations in the sector.

US-based cannabis and psychedelic consulting firm providing licensing, compliance, SOP, and operational support alongside strategic planning for psychedelic ventures.

Psychedelic intelligence platform that combines industry reporting with advisory and consultancy services for investors and operators, including strategic support and talent search.

Miami-based boutique consulting firm supporting cannabis and psychedelic organizations with product strategy, operational optimization, and capability development.